UK skin health specialist SkinBioTherapeutics has developed a probiotic powder targeting psoriasis – a product that centres on exciting advances in the gut-skin axis and holds wider promise for industry, its CEO says.
The skin microbiome continues to ignite interest as science fast advances and product innovations hit shelves, but where exactly are the biggest opportunities for industry and what will be the key challenges moving forward?
![Addressing skin health concerns via the gut-skin axis is the future of the skin microbiome space, according to the executive [Getty Images]](/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/cosmetics/cosmeticsdesign-europe.com/article/2021/09/02/skinbiotherapeutics-axisbiotix-probiotic-powder-for-psoriasis-holds-wider-promise-says-ceo/12788748-1-eng-GB/SkinBioTherapeutics-AxisBiotix-probiotic-powder-for-psoriasis-holds-wider-promise-says-CEO.jpg)
